多不饱和脂肪酸摄入与甲氨蝶呤治疗的早期类风湿关节炎患者炎症控制后疼痛的关系
本研究基于591例甲氨蝶呤单药治疗的早期类风湿关节炎患者,探讨膳食多不饱和脂肪酸摄入与治疗3个月后疼痛模式的关联。结果显示ω-3脂肪酸摄入与不可接受疼痛和难治性疼痛呈负相关,ω-6:ω-3比值与上述疼痛呈正相关,但与炎症性疼痛或全身炎症无关。
要点
- ω-3脂肪酸摄入与不可接受疼痛和难治性疼痛呈负相关。
- ω-6:ω-3脂肪酸比值与不可接受疼痛和难治性疼痛呈正相关。
- 多不饱和脂肪酸与炎症性疼痛或全身炎症无关联。
核心结论
- ω-3脂肪酸摄入与不可接受疼痛和难治性疼痛呈负相关,ω-6:ω-3比值与上述疼痛呈正相关。
- 多不饱和脂肪酸与炎症性疼痛或全身炎症无关联。
- ω-3脂肪酸补充剂与任何疼痛模式均无关联。
研究设计与样本
- 基于人群的前瞻性病例对照研究(流行病学类风湿关节炎调查),纳入591例甲氨蝶呤单药治疗的早期类风湿关节炎患者。
- 使用食物频率问卷评估多不饱和脂肪酸膳食摄入,并与治疗3个月后的疼痛数据关联,采用逻辑回归分析。
主要发现
- 治疗3个月后,125例(21.2%)患者存在不可接受疼痛,其中92例为难治性疼痛,33例为炎症性疼痛。
- ω-3脂肪酸摄入与不可接受疼痛的OR为0.57(95%CI 0.35-0.95),与难治性疼痛的OR为0.47(95%CI 0.26-0.84)。
- ω-6:ω-3脂肪酸比值与不可接受疼痛的OR为1.70(95%CI 1.03-2.82),与难治性疼痛的OR为2.33(95%CI 1.28-4.24)。
- 多不饱和脂肪酸与随访时炎症性疼痛、C反应蛋白水平及红细胞沉降率均无关联。
- ω-3脂肪酸补充剂与任何疼痛模式均无关联。
关键数值与推荐
- 不可接受疼痛定义为视觉模拟评分(VAS)>40 mm。
- 非炎症性/难治性疼痛定义为VAS>40 mm且C反应蛋白(CRP)水平<10 mg/L。
- 炎症性疼痛定义为VAS>40 mm且CRP水平>10 mg/L。
临床怎么用
- 在甲氨蝶呤治疗的早期类风湿关节炎患者中,可关注膳食ω-3脂肪酸摄入及ω-6:ω-3比值对残余疼痛的潜在影响。
- ω-3脂肪酸补充剂未显示与疼痛模式相关,不建议仅基于本研究结果将其用于疼痛管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate potential associations between dietary intake of polyunsaturated fatty acids (FAs) and pain patterns in early rheumatoid arthritis (RA) patients after 3 months of methotrexate (MTX) treatment. METHODS: We included 591 early RA patients with MTX monotherapy from a population-based prospective case-control study, the Epidemiological Investigation of Rheumatoid Arthritis. Dietary data on polyunsaturated FAs (food frequency questionnaires) were linked with data on unacceptable pain (visual analog scale [VAS] >40 mm), noninflammatory/refractory pain (VAS >40 mm and C-reactive protein [CRP] level <10 mg/liter), and inflammatory pain (VAS >40 mm and CRP level >10 mg/liter) after 3 months. Statistical analysis included logistic regression. RESULTS: After 3 months of MTX treatment, 125 patients (21.2%) had unacceptable pain, of which 92 patients had refractory pain, and 33 patients had inflammatory pain. Omega-3 FA intake was inversely associated with unacceptable pain and refractory pain (odds ratio [OR] 0.57 [95% confidence interval (95% CI) 0.35-0.95] and OR 0.47 [95% CI 0.26-0.84], respectively). The omega-6:omega-3 FA ratio, but not omega-6 FA alone, was directly associated with unacceptable pain and refractory pain (OR 1.70 [95% CI 1.03-2.82] and OR 2.33 [95% CI 1.28-4.24], respectively). Furthermore, polyunsaturated FAs were not associated with either inflammatory pain or CRP level and erythrocyte sedimentation rate at followup. Omega-3 FA supplementation was not associated with any pain patterns. CONCLUSION: Omega-3 FA was inversely associated with, and the omega-6:omega-3 FA ratio was directly associated with, unacceptable and refractory pain, but not with inflammatory pain or systemic inflammation. The inverse association between omega-3 FA and refractory pain may have a role in pain suppression in RA.
引用
- Lourdudoss C, Di Giuseppe D, Wolk A, et al. Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis Patients. Arthritis Care Res (Hoboken). 2018. PMID: 28371257. doi:10.1002/acr.23245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。